Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine vs. Fexofenadine in Seasonal Allergic Rhinitis
NCT00783211Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2004
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of desloratadine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Organon & Co. Primary endpoint: Change from Baseline in Mean AM Self-Rated Instantaneous Total Symptom Score (TSS) at 15 days. Started Aug 2004; status: completed.
02
Drugs
desloratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00783211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783211.